DT
GHDX

Diversified Trust’s Genomic Health, Inc. GHDX Stock Holding History

Diversified Trust’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,800
Closed -$217K – 522
2014
Q4 		$217K Buy
+6,800
New +$221K 0.02% 466
2014
Q2 		$268K Buy
+9,790
New +$261K 0.02% 488
2013
Q4 		$330K Buy
11,275
+525
+5% +$16.7K 0.03% 388
2013
Q3 		$329K Buy
10,750
+950
+10% +$31.8K 0.03% 387
2013
Q2 		$311K Buy
+9,800
New +$322K 0.04% 385

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Diversified Trust's GHDX Position: Q1 2015 in Review

Diversified Trust sold out of Genomic Health, Inc. (GHDX) in Q1 2015, closing a stake of 6,800 shares — an estimated $217K sold.

Diversified Trust first reported a position in GHDX in Q2 2013 and held it in 5 quarters. The position peaked at $330K in Q4 2013. 112 funds tracked by Wall St. Rank hold GHDX as of Q1 2015.

  • Diversified Trust reported no remaining Genomic Health, Inc. position as of Q1 2015 after selling out during the quarter.
  • Diversified Trust sold 6,800 Genomic Health, Inc. shares in Q1 2015, an estimated $217K.
  • Diversified Trust first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 5 quarters.
  • Diversified Trust's Genomic Health, Inc. position peaked at $330K in Q4 2013.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2015.

Based on Diversified Trust's 13F filing for Q1 2015, filed 29 Apr 2015.